P1350: THE EFFICACY OF UPFRONT HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN DECREASING RELAPSE RATE IN IV STAGE AND HIGH-INTERMEDIATE/HIGH IPI RISK GROUPS DLBCL
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000848264.70663.5a |
| _version_ | 1797281180731572224 |
|---|---|
| author | A. Koviazin L. Filatova I. Zyuzgin A. Artemyeva M. Motalkina Y. Chudinovskikh S. Volchenkov I. Poliatskin E. Dobrovolskaya S. Shalaev I. Ishmatova A. Zverkova D. Burda S. Elkhova T. Semiglazova |
| author_facet | A. Koviazin L. Filatova I. Zyuzgin A. Artemyeva M. Motalkina Y. Chudinovskikh S. Volchenkov I. Poliatskin E. Dobrovolskaya S. Shalaev I. Ishmatova A. Zverkova D. Burda S. Elkhova T. Semiglazova |
| author_sort | A. Koviazin |
| collection | DOAJ |
| first_indexed | 2024-03-07T16:54:24Z |
| format | Article |
| id | doaj.art-317c2551df0443f1b27b1fd8f004e87a |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T16:54:24Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-317c2551df0443f1b27b1fd8f004e87a2024-03-03T04:28:49ZengWileyHemaSphere2572-92412022-06-0161235123610.1097/01.HS9.0000848264.70663.5a202206003-01235P1350: THE EFFICACY OF UPFRONT HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN DECREASING RELAPSE RATE IN IV STAGE AND HIGH-INTERMEDIATE/HIGH IPI RISK GROUPS DLBCLA. Koviazin0L. Filatova1I. Zyuzgin2A. Artemyeva3M. Motalkina4Y. Chudinovskikh5S. Volchenkov6I. Poliatskin7E. Dobrovolskaya8S. Shalaev9I. Ishmatova10A. Zverkova11D. Burda12S. Elkhova13T. Semiglazova141 Department of Hematology and Chemotherapy with intensive care unit, NMRC of Oncology named after N.N.Petrov of MoH of Russia1 Department of Hematology and Chemotherapy with intensive care unit, NMRC of Oncology named after N.N.Petrov of MoH of Russia1 Department of Hematology and Chemotherapy with intensive care unit, NMRC of Oncology named after N.N.Petrov of MoH of Russia3 Department of Pathology1 Department of Hematology and Chemotherapy with intensive care unit, NMRC of Oncology named after N.N.Petrov of MoH of Russia1 Department of Hematology and Chemotherapy with intensive care unit, NMRC of Oncology named after N.N.Petrov of MoH of Russia1 Department of Hematology and Chemotherapy with intensive care unit, NMRC of Oncology named after N.N.Petrov of MoH of Russia3 Department of Pathology1 Department of Hematology and Chemotherapy with intensive care unit, NMRC of Oncology named after N.N.Petrov of MoH of Russia1 Department of Hematology and Chemotherapy with intensive care unit, NMRC of Oncology named after N.N.Petrov of MoH of Russia1 Department of Hematology and Chemotherapy with intensive care unit, NMRC of Oncology named after N.N.Petrov of MoH of Russia1 Department of Hematology and Chemotherapy with intensive care unit, NMRC of Oncology named after N.N.Petrov of MoH of Russia3 Department of Pathology1 Department of Hematology and Chemotherapy with intensive care unit, NMRC of Oncology named after N.N.Petrov of MoH of Russia2 North-Western State Medical University named after I.I.Mechnikovhttp://journals.lww.com/10.1097/01.HS9.0000848264.70663.5a |
| spellingShingle | A. Koviazin L. Filatova I. Zyuzgin A. Artemyeva M. Motalkina Y. Chudinovskikh S. Volchenkov I. Poliatskin E. Dobrovolskaya S. Shalaev I. Ishmatova A. Zverkova D. Burda S. Elkhova T. Semiglazova P1350: THE EFFICACY OF UPFRONT HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN DECREASING RELAPSE RATE IN IV STAGE AND HIGH-INTERMEDIATE/HIGH IPI RISK GROUPS DLBCL HemaSphere |
| title | P1350: THE EFFICACY OF UPFRONT HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN DECREASING RELAPSE RATE IN IV STAGE AND HIGH-INTERMEDIATE/HIGH IPI RISK GROUPS DLBCL |
| title_full | P1350: THE EFFICACY OF UPFRONT HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN DECREASING RELAPSE RATE IN IV STAGE AND HIGH-INTERMEDIATE/HIGH IPI RISK GROUPS DLBCL |
| title_fullStr | P1350: THE EFFICACY OF UPFRONT HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN DECREASING RELAPSE RATE IN IV STAGE AND HIGH-INTERMEDIATE/HIGH IPI RISK GROUPS DLBCL |
| title_full_unstemmed | P1350: THE EFFICACY OF UPFRONT HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN DECREASING RELAPSE RATE IN IV STAGE AND HIGH-INTERMEDIATE/HIGH IPI RISK GROUPS DLBCL |
| title_short | P1350: THE EFFICACY OF UPFRONT HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN DECREASING RELAPSE RATE IN IV STAGE AND HIGH-INTERMEDIATE/HIGH IPI RISK GROUPS DLBCL |
| title_sort | p1350 the efficacy of upfront high dose chemotherapy with autologous stem cell transplantation in decreasing relapse rate in iv stage and high intermediate high ipi risk groups dlbcl |
| url | http://journals.lww.com/10.1097/01.HS9.0000848264.70663.5a |
| work_keys_str_mv | AT akoviazin p1350theefficacyofupfronthighdosechemotherapywithautologousstemcelltransplantationindecreasingrelapserateinivstageandhighintermediatehighipiriskgroupsdlbcl AT lfilatova p1350theefficacyofupfronthighdosechemotherapywithautologousstemcelltransplantationindecreasingrelapserateinivstageandhighintermediatehighipiriskgroupsdlbcl AT izyuzgin p1350theefficacyofupfronthighdosechemotherapywithautologousstemcelltransplantationindecreasingrelapserateinivstageandhighintermediatehighipiriskgroupsdlbcl AT aartemyeva p1350theefficacyofupfronthighdosechemotherapywithautologousstemcelltransplantationindecreasingrelapserateinivstageandhighintermediatehighipiriskgroupsdlbcl AT mmotalkina p1350theefficacyofupfronthighdosechemotherapywithautologousstemcelltransplantationindecreasingrelapserateinivstageandhighintermediatehighipiriskgroupsdlbcl AT ychudinovskikh p1350theefficacyofupfronthighdosechemotherapywithautologousstemcelltransplantationindecreasingrelapserateinivstageandhighintermediatehighipiriskgroupsdlbcl AT svolchenkov p1350theefficacyofupfronthighdosechemotherapywithautologousstemcelltransplantationindecreasingrelapserateinivstageandhighintermediatehighipiriskgroupsdlbcl AT ipoliatskin p1350theefficacyofupfronthighdosechemotherapywithautologousstemcelltransplantationindecreasingrelapserateinivstageandhighintermediatehighipiriskgroupsdlbcl AT edobrovolskaya p1350theefficacyofupfronthighdosechemotherapywithautologousstemcelltransplantationindecreasingrelapserateinivstageandhighintermediatehighipiriskgroupsdlbcl AT sshalaev p1350theefficacyofupfronthighdosechemotherapywithautologousstemcelltransplantationindecreasingrelapserateinivstageandhighintermediatehighipiriskgroupsdlbcl AT iishmatova p1350theefficacyofupfronthighdosechemotherapywithautologousstemcelltransplantationindecreasingrelapserateinivstageandhighintermediatehighipiriskgroupsdlbcl AT azverkova p1350theefficacyofupfronthighdosechemotherapywithautologousstemcelltransplantationindecreasingrelapserateinivstageandhighintermediatehighipiriskgroupsdlbcl AT dburda p1350theefficacyofupfronthighdosechemotherapywithautologousstemcelltransplantationindecreasingrelapserateinivstageandhighintermediatehighipiriskgroupsdlbcl AT selkhova p1350theefficacyofupfronthighdosechemotherapywithautologousstemcelltransplantationindecreasingrelapserateinivstageandhighintermediatehighipiriskgroupsdlbcl AT tsemiglazova p1350theefficacyofupfronthighdosechemotherapywithautologousstemcelltransplantationindecreasingrelapserateinivstageandhighintermediatehighipiriskgroupsdlbcl |